Cookson, R., Griffin, S., Norheim, O. F., & Culyer, A. J. (Eds.). (2020). Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs. Oxford: Oxford University Press, 2020. Paperback (ISBN-13: 9780198838197). £ 28.03. 365 pp

Author(s):  
Sean Campbell Sinclair
Author(s):  
Heather Taffet Gold

Cost-effectiveness analysis is a tool used to systematically and quantitatively compare trade-offs between health outcomes and costs of alternative health care interventions with standards set for the United States. Many recommendations, however, may not coalesce with implementation science methods. There is a lack of consensus for economic evaluation in implementation science that has resulted in conflicting norms and conventions, which in turn make analyses difficult to compare, raise quality concerns, and may put the relevance of research into question. This chapter suggests new standards as areas for future research to improve the quality, rigor, transparency, and ultimately comparability of cost-effectiveness analyses in implementation science.


Distributional cost-effectiveness analysis aims to help healthcare and public health organizations make fairer decisions with better outcomes. Standard cost-effectiveness analysis provides information about total costs and effects. Distributional cost-effectiveness analysis provides additional information about fairness in the distribution of costs and effects—who gains, who loses, and by how much. It can also provide information about the trade-offs that sometimes occur between efficiency objectives such as improving total health and equity objectives such as reducing unfair inequality in health. This is a practical guide to a flexible suite of economic methods for quantifying the equity consequences of health programmes in high-, middle-, and low-income countries. The methods can be tailored and combined in various ways to provide useful information to different decision makers in different countries with different distributional equity concerns. The handbook is primarily aimed at postgraduate students and analysts specializing in cost-effectiveness analysis but is also accessible to a broader audience of health sector academics, practitioners, managers, policymakers, and stakeholders. Part I is an introduction and overview for research commissioners, users, and producers. Parts II and III provide step-by-step technical guidance on how to simulate and evaluate distributions, with accompanying hands-on spreadsheet training exercises. Part IV concludes with discussions about how to handle uncertainty about facts and disagreement about values, and the future challenges facing this young and rapidly evolving field of study.


2017 ◽  
Vol 20 (2) ◽  
pp. 206-212 ◽  
Author(s):  
Richard Cookson ◽  
Andrew J. Mirelman ◽  
Susan Griffin ◽  
Miqdad Asaria ◽  
Bryony Dawkins ◽  
...  

Author(s):  
Richard Cookson ◽  
Susan Griffin ◽  
Ole F. Norheim ◽  
Anthony J. Culyer

Distributional cost-effectiveness analysis (DCEA) aims to help healthcare and public health organizations make fairer decisions with better outcomes. Standard cost-effectiveness analysis provides information about total costs and effects. DCEA provides additional information about fairness in the distribution of costs and effects—who gains, who loses, and by how much. It can also provide information about the trade-offs that sometimes occur between efficiency objectives: improving total health and equity objectives, such as reducing unfair inequality in health. This chapter introduces DCEA and provides an overview of the book contents. After summarizing the motivation, aims, and scope of the book, it concludes with a section on how to use the book and which chapters are likely to be useful for which audiences. Chapters 1, 2, 3, and 4 introduce the basic concepts and are likely to be useful to research producers and research users alike, so we recommend reading these first before turning to specific methods chapters.


Sign in / Sign up

Export Citation Format

Share Document